Add-on therapy with EPS® 7630 prolongs time to first exacerbation and improves health-related quality of life in COPD

Authors
Category Primary study
ConferenceRespiration
Year 2013
This article has no abstract
Epistemonikos ID: 364627950cde733492291177c21d5431ebd19c78
First added on: Apr 30, 2026